Russia’s Sputnik V Covid vaccine shows 91.6% efficacy in Phase-III trial; Equal effectiveness in people aged above 60

Total
0
Shares

Recently, PM Modi’s Centre panel rejected Sputnik V Covid drug for emergency-use approval.

Via


You May Also Like